Abstract P5-06-07: Luminal-to-basal subtype conversion is governed by TP53-GATA3 mutational status and is targetable by MAPK inhibition in patients with breast cancer
Year: 2025
Type: conference-abstract
Source: Clinical Cancer Research
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4411285824
